Paul W. Price, Ph.D. is a Senior Consultant at Biologics Consulting with over 25 years' experience in the Biotechnology Industry. Paul is part of the CMC-Analytics and Formulations Team, and also serves with the Early Development and Biosimilars Task Forces. He assists clients with design and implementation of biologics development and manufacturing projects; design, development, qualification and validation of process and release analytics; developing Project Management strategies for product development including Risk Management, Quality Oversight, and Technology Transfer; and Identification, management, preparation, and submission of Government Contract and Grant Proposals.
Paul's career has included work at Biocraft Laboratories and Barr Laboratories, Beckman Coulter, Inc., Abeome Corp., and Paragon Bioservices, as well as working as an independent consultant. As Principle Scientist at Paragon, he lead the planning and implementation of biologics development projects, including vaccines, viral-vectored products, monoclonal antibodies, protein therapeutics, and diagnostics. In addition, Paul held the position of Director of Government Grants and Contracts, where he oversaw the development, management, and submission of Government contract proposals and Grant applications. He is a SME in immunology, infectious diseases, microbiology, virology, and cancer, as well as biological assay development, Risk Management, and Quality oversight.
Dr. Price holds a B.S. in Marine Biology and a M.S. In Microbiology from Fairleigh Dickinson University, he earned his Ph.D. in Biology (Immunology) from Georgetown University, and completed post-doctoral studies at the University of Maryland, School of Medicine.